Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid ...

Novo Nordisk Pakistan hosted “Unordinary Partnerships to Shape a Healthier Tomorrow” that brought together healthcare ...

More than 80 U.S. lawmakers asked the FDA to stop counterfeit GLP-1 drugs linked to Chinese suppliers from entering the ...

A majority of Americans have experienced the frustration of getting a healthcare insurance denial, often times finding no ...

Cipla is looking at the whole GLP-1 category and not just Semaglutide alone, says Cipla CEO Umang Vohra in a post-results ...

Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of the Company's senior executives for ...

Health experts have expressed deep concern over the alarming rise in obesity and depression among Pakistan's youth, revealing ...

India's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 ...

Pharmaceutical company Simtra has bought a 65-acre property from Cook Group, including a 300,000 square-foot facility, to ...

Editors: Story has been updated from original, with material from the president of the Arizona Obesity Organization. Slug: ...

The council describes itself as a "national, non-partisan not-for-profit with members from both government & the private sector, and says that "virtually all major players involved in public ...